A phase IV study evaluating QT interval, pharmacokinetics, and safety following fractionated dosing of gemtuzumab ozogamicin in patients with relapsed/refractory CD33-positive acute myeloid leukemia
Titel:
A phase IV study evaluating QT interval, pharmacokinetics, and safety following fractionated dosing of gemtuzumab ozogamicin in patients with relapsed/refractory CD33-positive acute myeloid leukemia
Auteur:
Montesinos, Pau Kota, Vamsi Brandwein, Joseph Bousset, Pierre Benner, Rebecca J. Vandendries, Erik Chen, Ying McMullin, Mary Frances